8 October 2026

Cancer PBAC Pharmaceuticals

Goserelin wins six-month PBS reprieve

8 October 2026

Aged Care AIHW Pharmaceuticals

Polypharmacy hits 40% of over-75s

8 October 2026

FDA Haematology Pharmaceuticals

FDA approves interferon conjugate for essential thrombocythemia

10 September 2026

Diabetes Pharmaceuticals

GLP-1 RAs: what longer-term use is revealing

10 September 2026

FDA Pharmaceuticals

FDA approves first hepcidin-mimicking drug for polycythaemia vera

27 August 2026

Pharmaceuticals Respiratory

TSANZ seeks transparency on tobacco-backed medicines

27 August 2026

Pharmaceuticals TGA

Lilly targets black market retatrutide

27 August 2026

oncology PBAC PBS Pharmaceuticals

PBAC nod for cancer drugs

13 August 2026

PBS Pharmaceuticals

GBMA targets medicine shortages

16 July 2026

Breast cancer PBS Pharmaceuticals

AstraZeneca announces new access program for cancer implant

16 July 2026

Pharmaceuticals Prostate cancer

Estradiol patches rival standard ADT in locally advanced prostate cancer

16 July 2026

Cancer Women

Progestogen contraceptives associated with increased meningioma risk

4 June 2026

Leukaemia PBS Pharmaceuticals

PBS listing opens access to breakthrough therapy

4 June 2026

ASCO pancreatic cancer Pharmaceuticals

Standing ovation at ASCO for cancer pill

21 May 2026

Drugs Pharmaceuticals TGA

Peptide craze sparks Lancet warning

7 May 2026

PBS TGA

New cancer drug subsidies and registrations

23 April 2026

Cancer Clinical research

Triplet cuts post-transplant progression

23 April 2026

PBS Pharmaceuticals

Aussie-made hereditary angioedema therapy gains PBS listing

23 April 2026

Gastrointestinal cancer Pharmaceuticals

Imatinib improves outcomes in exon 9 GIST

9 April 2026

Haematology Research

Novel T-cell therapy trial kicks off at Peter Mac